Skip to content
Home/Companies/MedTech/Transdermal Diagnostics
Transdermal Diagnostics

Transdermal Diagnostics

MedTech·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Transdermal Diagnostics?

Transdermal Diagnostics is an American MedTech company, currently owned by Elbow Beach Investments since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elbow Beach Investments
Investor
Elbow Beach Investments
Elbow Beach Capital · 2022 · Impact

Key facts

HQUnited States
SectorMedTech
Websitetransdermal-diagnostics.com

More from Elbow Beach Capital

Other portfolio companies in the same fund.

Barton Blakeley Technologies
Active
ClimateTechUK· 2024
Allye Energy
Allye Energy
Active
ClimateTechUK· 2023
EnsiliTech
EnsiliTech
Active
BiotechUK· 2023
Fieldwork Robotics
Fieldwork Robotics
Active
AgTechUK· 2023
Mettle
Mettle
Active
HealthTechUK· 2023
QV Bioelectronics
Active
MedTechUK· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Transdermal Diagnostics?

Transdermal Diagnostics is currently owned by Elbow Beach Investments, through Elbow Beach Capital, since 2023.

When did Elbow Beach Investments acquire Transdermal Diagnostics?

Elbow Beach Investments acquired Transdermal Diagnostics in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue